Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
20.23M
Cash
2.824M
Avg Qtr Burn
-1.177M
Short % of Float
12.66%
Insider Ownership
27.21%
Institutional Own.
5.96%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ketamir-2 Details Treatment Resistant Depression, Major depressive disorder, Acute Suicidal Ideation and Behavior, Post-traumatic stress disorder, Mental health | IND Submission |